معرفی
Neal Fischbach, MD, is an Assistant Professor of Medicine (Medical Oncology) at Yale School of Medicine and Assistant Medical Director of the Clinical Trials Office for the Smilow Cancer Hospital Care Center Network. He specializes in breast cancer treatment and coordinates clinical trial activities across Yale’s care centers. Dr. Fischbach completed his medical training at Harvard Medical School, followed by residency in internal medicine and fellowship in hematology/oncology at UCSF.
Education:
- MD: Harvard Medical School (1995)
- Residency: Internal Medicine, UCSF (1999)
- Fellowship: Hematology/Oncology, UCSF (2002)
Research Interests: Dr. Fischbach focuses on improving breast cancer care through clinical trials and translational research. His work includes studying HER2 protein dynamics post-neoadjuvant therapy, genomic profiling in metastatic breast cancer, and barriers to clinical trial participation for underrepresented minorities. He emphasizes patient-centered approaches to address both cancer treatment and its psychosocial impacts.
Publications: His recent work spans perioperative chemotherapy for pancreatic cancer, weight management in breast cancer patients, and AI-driven clinical trial accessibility. These studies highlight advancements in therapy efficacy, biomarker analysis, and health equity.
Awards:
- Connecticut Magazine Top Docs (2015, 2016)
- Castle Connolly Top Doctors (2014)
- Best Doctors (Fairfield/Westport and Connecticut Magazines, 2014)
Grants & Trials: He oversees multiple clinical trials, including phase II/III studies on immunotherapy combinations and adjuvant therapies. His role in trial coordination ensures cutting-edge treatments reach diverse patient populations.
Labs & Teams: Collaborates with Yale Cancer Center’s breast oncology team and translational research groups to advance personalized medicine strategies.